-
Research priorities for expansion of opioid use disorder treatment in the community pharmacy.
Jarrett JB, Bratberg J, Burns AL, Cochran G, DiPaula BA, Dopp AL, Elmes A, Green TC, Hill LG, Homsted F, Hsia S, Matthews ML, Ghitza UE, Wu L, Bart G. Research priorities for expansion of opioid use disorder treatment in the community pharmacy. Substance Abuse 2023;44(4):264-276.
-
Assessment of screening tools to identify substance use disorders among adolescents.
Levy S, Brogna M, Minegishi M, Subramaniam G, McCormack J, Kline M, Menzin E, Allende-Richter S, Fuller A, Lewis M, Collins J, Hubbard Z, Mitchell SG, Weiss RD, Weitzman E. Assessment of screening tools to identify substance use disorders among adolescents. JAMA Network Open 2023;6(5):e2314422.
-
Potential effect of antidepressants on remission from cocaine use disorder — A nationwide matched retrospective cohort study.
Gao Z, Winhusen TJ, Gorenflo M, Ghitza UE, Nunes EV, Saxon AJ, Korthuis PT, Brady K, Luo SX, Davis PB, Kaelber DC, Xu R. Potential effect of antidepressants on remission from cocaine use disorder -- A nationwide matched retrospective cohort study. Drug & Alcohol Dependence 2023;251:110958.
-
Prevalence of cannabis use disorder and reasons for use among adults in a US state where recreational cannabis use is legal.
Lapham GT, Matson TE, Bobb JF, Luce C, Oliver MM, Hamilton LK, Bradley KA. Prevalence of cannabis use disorder and reasons for use among adults in a US state where recreational cannabis use is legal. JAMA Network Open 2023;6(8):e2328934.
-
Identifying patients with opioid use disorder using International Classification of Diseases (ICD) codes: Challenges and opportunities.
Osterhage KP, Hser Y, Mooney LJ, Sherman S, Saxon AJ, Ledgerwood M, Holtzer CC, Gehring MA, Clingan SE, Curtis ME, Baldwin L. Identifying patients with opioid use disorder using International Classification of Diseases (ICD) codes: Challenges and opportunities. Addiction 2023;119(1):160-168.
-
Associations between stimulant use and return to illicit opioid use following initiation onto medication for opioid use disorder.
Foot C, Korthuis PT, Tsui JI, Luo SX, Chan B, Cook RR. Associations between stimulant use and return to illicit opioid use following initiation onto medication for opioid use disorder. Addiction 2023;119(1):149-157.
-
Implementation of substance use screening in rural federally-qualified health center clinics identified high rates of unhealthy alcohol and cannabis use among adult primary care patients.
McNeely J, McLeman B, Gardner T, Nesin N, Amarendran V, Farkas S, Wahle A, Pitts S, Kline M, King J, Rosa CL, Marsch LA, Rotrosen J, Hamilton L. Implementation of substance use screening in rural federally-qualified health center clinics identified high rates of unhealthy alcohol and cannabis use among adult primary care patients. Addiction Science & Clinical Practice 2023;18:56.
-
Capturing drug use patterns at a glance: An n-ary word sufficient statistic for repeated univariate categorical values.
Odom GJ, Brandt L, Castro C, Luo SX, Feaster DJ, Balise RR, CTN-0094 Team. Capturing drug use patterns at a glance: An n-ary word sufficient statistic for repeated univariate categorical values. PLoS One 2023;18(9):e0291248.
-
Risks of returning to opioid use at treatment entry and early in opioid use disorder treatment: Role of non-opioid substances.
Castillo F, Hu M, Liu Y, Balise RR, Weiss RD, Rotrosen J, Nunes EV, Saxon AJ, Feaster DJ, Luo SX. Risks of returning to opioid use at treatment entry and early in opioid use disorder treatment: Role of non-opioid substances. Drug and Alcohol Dependence 2023;251:110926.
-
Association between cannabis use disorder symptom severity and probability of clinically-documented diagnosis and treatment in a primary care sample.
Matson TE, Williams EC, Lapham GT, Oliver M, Hallgren KA, Bradley KA. Association between cannabis use disorder symptom severity and probability of clinically-documented diagnosis and treatment in a primary care sample. Drug and Alcohol Dependence 2023;251:110946.